Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RRAGAP1 antisense RNA 1 (RRAGAP1-AS1)
- Target
- RRAGAP1-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other (does not fit typical receptor/enzyme families)
01
Overview
RRAGAP1 antisense RNA 1 (RRAGAP1-AS1), also known as LINC02302 or LOC101927418, is a long non-coding RNA (lncRNA) gene. According to available sources, it is annotated in the NCBI Gene database but has no experimentally characterized biological function or disease association reported in the scientific literature to date[4]. It is a member of the antisense lncRNAs, a diverse class of RNA molecules generally involved in the regulation of gene expression, but its specific roles, molecular partners, or clinical implications remain uncharacterized[4]. There is no published evidence that RRAGAP1-AS1 is a validated or proposed therapeutic target, nor is it currently known to interact with drugs or serve as a clinically relevant biomarker.
- Other names
- LINC02302LOC101927418
02
Biological functions
Unknown (no direct evidence found for well-defined biological functions in current literature)Based on lncRNA classification, possible involvement in gene expression regulation, but no specific studies for RRAGAP1-AS1 were found
03
Disease associations
Unknown (no evidence associating RRAGAP1-AS1 directly with any disease in literature reviewed)No reports linking RRAGAP1-AS1 to cancer, inflammation, neurodegeneration, or other pathologies
Beyond the preview
Go deeper on RRAGAP1 antisense RNA 1 (RRAGAP1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RRAGAP1 antisense RNA 1 (RRAGAP1-AS1).